These grants provide up to £30,000 over 1-2 years for research costs, to support Clinical Lecturers who are looking to develop and strengthen their research careers.
Round 29 is now closed to applications.
These grants provide up to £30,000 over 1-2 years for research costs, to support Clinical Lecturers who are looking to develop and strengthen their research careers.
Round 29 is now closed to applications.
The above diagram illustrates the application process for the two rounds of the Starter Grants award and provides rough dates for each stage. Please note that these dates are to serve as a guide only and can be subject to change .
About the scheme
This scheme was launched in October 2008 as a partnership between the Academy and the Wellcome Trust. Current funders of the scheme are the Wellcome Trust, British Heart Foundation (since 2011), Versus Arthritis (since 2012), Medical Research Council (since 2013), Diabetes UK (since 2016), the British Thoracic Society (through the Helen and Andrew Douglas bequest for the use of research into tuberculosis control; since 2018), and the Association of Physicians of Great Britain & Ireland (since 2020). We recently celebrated ten years since the launch of the Starter Grants for Clinical Lecturers scheme. The achievements of the awardees are cause for celebration. To mark this, we have published our ‘Starter for 10: a decade of supporting academic Clinical Lecturers’ report which sets out the successes and includes case studies drawn from the last decade.
The grants provide modest ‘starter’ funds to enable research active Clinical Lecturers to pursue their research work. Clinical Lecturer posts provide a salary but often do not come with the funding to support the costs of the research. This scheme was designed to help bridge this gap by providing Clinical Lecturers with access to modest research funds for up to two years. It gives them experience of preparing a research grant application and helps them establish their research portfolios by providing funding for research consumables.
So far we have supported 618 Clinical Lecturers through 27 rounds of funding, with grants totalling over £17.5 million. The 10th anniversary report (2018) and the latest annual report (2020) can be accessed on the right hand side of this page.
In November 2020, the academy launched an exciting new programme called PILLAR (Promoting Innovation, Learning, Leadership And Resilience in the research community). This programmer offers support to our grant awardees. For more information please visit the main PILLAR page here.
The grants are intended as start-up funding and as such are not intended for applicants who have already obtained substantial funding through, for example, Clinician Scientist Fellowships, New Investigator Awards or large project grants.
All eligible applicants must:
1. Have a PhD or MD.
2. Hold a medical, dental or veterinary undergraduate degree and be registered with the General Medical Council, General Dental Council or Royal College of Veterinary Surgeons.
3. Hold a clinical contract at a UK institution.
If you are a clinician in human or dental medicine, you must also:
1. Be a research-active Clinical Lecturer
2. Hold an NTN or NTN(A)
3. Be within higher specialty training.
4. Have undertaken a substantial period of research equivalent to a PhD or research MD, if you have qualified abroad with an MD.
5. Note the following eligibility criteria relating to the timing of your CCT:
Senior Clinical Lecturers and Clinical Psychologists are not eligible for this scheme.
If you are a clinician in veterinary medicine, you must be either:
1. A research-active Veterinary Specialist in Training (Resident/Senior Clinical Training Scholar) within an approved Specialist Training Programme with secured and protected research time throughout the proposed project.
2. A research-active Veterinary Clinician or Veterinary Pathologist with Veterinary Specialist Board qualification or eligibility and within the 3 year (probationary) period of your first University appointment and with secured and protected research time throughout the proposed project. If your position is that of a Senior Lecturer but are still within the three year probationary period then you are still eligible for this scheme.
We are currently reviewing our eligibility criteria for veterinary applicants. We would encourage you to get in contact with the Office if you would like to discuss your eligibility to the scheme.
Please review the scheme FAQ document for full details on eligibility.
Please contact the grants team if you have any other queries about the scheme at firstname.lastname@example.org
This scheme is targeted at those who are in the earlier years of their Clinical Lecturer appointment. You should not already have obtained substantial funding from other sources, for example a Clinician Scientist Fellowship, New Investigator Award or large project grant.
The maximum grant available is £30,000. This can be spread over one to two years to contribute towards directly incurred research costs, including (but not limited to) consumables, access charges, access to data sets, essential software and licences, and equipment.
Grants cannot be used to pay for your personal salary costs or to employ research assistants, PhD students or postdoctoral staff.
The Academy recognises the challenges clinicians face when managing a clinical and a research career with family and caring commitments. During the review process, prior career breaks will be taken into account when evaluating a candidate’s research output and progress. If you are successful, you will be able to apply for a no-cost extension to your grant to account for periods of absence or delays in your project during your award. For an example of the success such Starter Grant holders can achieve, please click here.
Successful applicants cannot reapply. Unsuccessful applicants are limited to one resubmission.
Like all UK post-doctoral clinicians, Starter Grant holders are eligible for the Academy's one-to-one mentoring scheme and are encouraged to contact the Office regarding this.
The current members of the selection panel are:
Professor Rosalind Smyth CBE FMedSci (Chair), UCL Great Ormond Street Institute of Child Health
Professor Ashley Blom FMedSci, University of Bristol
Professor Cyrus Cooper OBE FMedSci, University of Southampton
Professor Adnan Custovic FMedSci, Imperial College London
Professor Peter Ghazal OBE FMedSci, Cardiff University
Professor Deborah Lawlor CBE FMedSci, University of Bristol
Professor Ziad Mallat FMedSci, University of Cambridge
Professor Danny McAuley FMedSci, Queen's University Belfast
Professor Paul Moss OBE FMedSci, University of Birmingham
Professor Sir Munir Pirmohamed FMedSci, University of Liverpool
Professor Eleanor Riley FRSE FMedSci, University of Edinburgh
Professor Sir Aziz Sheikh OBE FRSE FMedSci, University of Edinburgh
Applicants should not approach panel members to discuss their application. All queries should be directed to the secretariat (email@example.com).
All Starter Grant Holders are required to report via Researchfish annually by the end of March each year throughout their grant and for five years after the completion of their award. Click here for full reporting instructions.
A report of Starter Grant Holders' research outcomes submitted to us during our Researchfish submission window in 2020 is available for download on the right hand side of this page.
You will also need to submit a Final Expenditure Report within three months of the end of your grant in addition to submitting Researchfish data. The final expenditure report blank template can be accessed by clicking on 'reporting' on your Flexi-Grant award page. If you require further assistance please do contact the Academy's grants team at firstname.lastname@example.org.
Adam Al-Diwani, University of Oxford, Cervical lymph node aspirations: cellular and molecular phenotyping at an emerging neuro-immune nexus
Rubika Balendra, University College London, Investigating mechanisms of RNA dysregulation in C9orf72-associated motor neuron disease and frontotemporal dementia
Lucy Beishon, University of Leicester, Vascular mEchanismS in, dePression, dementiA, and deliRum: The VESPAR project
Floryne Buishand, Royal Veterinary College, University of London, Identification of novel druggable targets in canine insulinoma through single-cell transcriptomic analysis
Nicholas Cunniffe, University of Cambridge, Examining the long-term effects of the combination of metformin and clemastine on remyelination and neuroprotection; a follow-up study of the Cambridge Centre for Myelin Repair trial Two
Kate Duhig, University of Manchester, Developing MRI sequences to Assess maternal cardiac and Placental function in women with HyperteNsion in prEgnancy (DAPHNE)
Dermot Linden, Queen's University Belfast, Epstein-Barr Virus suppression in Chronic Obstructive Pulmonary Disease (EViSCO): A mechanistic study to evaluate the sputum transcriptome and microbiome in moderate-to-severe COPD
Emma Rose McGlone, Imperial College London, Hepatic glucagon sensitivity before and after bariatric surgery: use of a plasma biomarker to predict resolution of metabolic-associated liver disease
Michaela Reichmann, University of Southampton, Multidimensional transcriptomic analysis of tuberculosis granulomas to define pathophysiological mechanisms
Ola Rominiyi, University of Sheffield, High-grade glioma treatment design through mapping spatial differences in the DNA damage response of cancer stem cells
Neil Ryan, University of Bristol, MicrosatEllite Womb Surveillance (MEWS) study
Yazan Sulaiman Khaled, University of Leeds, Developing a novel theranostic nanoparticle for precision surgery in pancreatic cancer
Wendy Thompson, University of Manchester, Developing ways to evaluate process during the clinical trial of a dental antibiotic stewardship intervention
Oliver Todd, University of Leeds, Stratified hypertension management in later life: establishment of cohort linkage between ambulatory blood pressure measurements and routine health and social care data in Connected Bradford
Tabitha Turner-Stokes, Imperial College London, From human genetics to monocyte-specific disease mechanisms in systemic lupus erythematosus
Yize Wan, Queen Mary University of London, Acute illness as a driver of long-term disease and health inequality across socioeconomic and ethnic groups
Hannah Woodcock, University of Cambridge, Investigating lung epithelial progenitor cell fate in the developing human lung
Kathryn Allan, University of Glasgow, Investigating the impact of Coxiella burnetii infection on dairy cattle in Scotland.
Emily Bowen, University of Bristol, Investigating Shiga toxin-induced endothelial glycocalyx dysfunction as a potential therapeutic target in Haemolytic Uraemic Syndrome
Mitchell Chen, Imperial College London, Deep Learning and Radiomics-based Cardiovascular Disease Assessment on Ungated Contrast Enhanced Computed Tomography and its Integration in a Clinical Predictive Model for Patients with Non-Small Cell Lung Cancer
Radoslaw Debiec, University of Leicester, Bicuspid aorRtic vAlVe gEnetic research – tHoracic aortic 18F-fluoridE microcAlcification to monitoR aorTopathy (BRAVE-HEART substudy)
Lydia Finney, Imperial College London, Investigating the role of specialist pro-resolving mediators in viral exacerbations of chronic obstructive pulmonary disease
Daniel Fudulu, University of Bristol, Metabolomoics and clinical based predictive modles for acute kidney injury after coronary atery bypass grafting
Rebecca Gosling, University of Sheffield, Comprehensive modelling of myocardial ischaemic bur
Timothy Hardy, Newcastle University, Characterisation of somatic mutation analysis in cell free DNA of patients with Non Alcoholic Fatty Liver Disease
Jamilla Hussain, Hull & York Medical School, Health inequalities related to ethnicity and socio-economic position at the end-of-life
David Hutchings, University of Manchester, Why is lamin cardiomyopathy a perfect storm for arrhythmias?
Eleni Louka, University of Oxford, Investigating the mechanisms of relapse in Juvenile Myelomonocytic Leukaemia (JMML)
Imran Noorani, Francis Crick Institute, Defining the molecular impact of extrachromosomal oncogenes on cellular interactions in the glioblastoma microenvironment
Majd Protty, Cardiff Univeristy, Investigating the role of procoagulant enzymatically oxidized phospholipids in arterial thrombosis using in vivo models
Mahim Qureshi, University of Bristol, Composite primary endpoints for randomised controlled trials of invasive and surgical procedures
Rebecca Spencer, University of Leeds, Circulating placental extracellular vesicles as non-invasive placental biopsies and sources of diagnostic markers in fetal growth restriction
Tathyane Teshima, University College London, Identifying the cellular and genetic profile of salivary gland damage in Sjogren’s Syndrome with focus on how specific tissues influence disease at single-cell level
Ganesh Vigneswaran, University of Southampton, Machine learning to identify predictors of outcome and survival in the treatment of mUM (metastatic uveal melanoma) with M-PHP (melphalan percutaneous hepatic perfusion)
Akira Wiberg, University of Oxford, Developing a single cell atlas of the median nerve microenvironment in the carpal tunnel
Anam Anzark, Queen Mary University of London, Investigating a role of seizures in promoting progression of Glioblastoma Multiforme
Damiano Giuseppe Barone, University of Cambridge School of Clinical medicine, Minimally Invasive Spinal Cord Stimulation for chronic pain
Andrew Bell, University of Glasgow, The role of distinct populations of spinal excitatory interneurons in post-operative pain
Camilla Clark, St George's University Hospitals NHS, How we understand our emotions: Is alexithymia following traumatic brain injury a generalised failure of interoception?
Jonathan Evans, University of Exeter Medical School, Cross-Cultural Validation and Calibration of the PROMIS
Michael FitzPatrick, University of Oxford, Elucidating functional and spatial characteristics of CD8+ T cell populations in coeliac disease
Anne-Lise Goddings, University College London, The association between glycaemic control in young people with Type 1 diabetes mellitus and executive functioning in social contexts: a pilot study
Ankur Gupta-Wright, University College London, Improving diagnosis of presumptive TB in hospitalised patients in Malawi
Neil Halliday, University College London, Assessment of Treg function, CD28 costimulation and immune dysregulation in autoimmune liver diseases
James Howard, Imperial College London, Diastolic function assessment with cardiac magnetic resonance imaging and echocardiography: a scan-rescan study
Thomas Massey, Cardiff University, Using genetic modifiers to investigate the molecular mechanisms of repeat expansion in Huntington’s disease
James Masters, University of Oxford, Collecting Data on hip fracture surgery in sub-saharan africa (Hip fracturE surGery In sub-sahaRan Africa-HEGIRA)
Susanna Mills, Newcastle University, Mixed-methods study to generate evidence to inform weight management interventions in adult secure care mental health inpatient settings
Sophie Patterson, University of Lancaster, Expansion of Remote Contraceptive Services in England: Implications for Inequalities in Women’s Reproductive Health
Helen Payne, Imperial College London, Prevalence of cytomeglaovirus and Epstein Barr virus and associated immune-activation and inflammation in adolescents with perinatally-acquired HIV
Muhammad Rashid, Keele University School of Medicine, REadmissions, Adverse Complications and ouTcomes following Acute Myocardial Infarction (REACT-AMI) study
Jennifer Rayner, University of Oxford, Mapping complete energetic pathways in the human heart using magnetic resonance spectroscopy
Maria Rogdaki, King's College London, Determining the molecular mechanisms of psychosis and developing a cellular platform for novel drug discovery: From brain to cell and back again
Jakub Scaber, University of Oxford, Investigating selective vulnerability in C9orf72 positive amyotrophic lateral sclerosis using induced pluripotent stem cell derived motor and sensory neurons
Charlotte-Eve Short, Imperial College London, The immunological basis for increased Preterm Birth in HIV-1 infected pregnant women and the influence of different classes of antiretroviral therapy
Norman Shreeve, University of Cambridge School of Clinical Medicine, The fetal microglial response to glucocorticoid exposure in utero
Nicola Tempest, University of Liverpool, Preliminary study, characterising the region-specific abnormalities in the endometrium of women with recurrent implantation failure
Stephanie Worton, University of Manchester, Investigating novel treatments for maternal vascular dysfunction in the STOX1 model of pre-eclampsia; the missing link in the translational pathway
Amir Youshani, University of Manchester, Characterisation of senescence-associated secretory phenotype in glioblastoma
Tian Zhao, University of Cambridge, The effect of low-dose interleukin-2 on atherosclerotic plaque immune cells in patients undergoing carotid endarterectomy
Sarah Al-Bachari, University of Lancaster, ENIGMA-PD-Vasc: An international multicentre analysis of cerebral vascular changes in Parkinson's disease
Nay Aung, Queen Mary University of London, Leveraging natural language processing, genomics and imaging to evaluate the determinants of adverse cardiovascular events
Thomas Cope, University of Cambridge School of Clinical Medicine, The impact of neurodegeneration on neuronal coding – 7T fMRI in frontal and temporal aphasia
Vitor de Carvalho Moreno das Neves, King's College London, Investigating periodontitis host-related factors at molecular level: healthy-to-diseased periodontium single-cell characterisation and molecular dynamics of aging
Harveer Dev, University of Cambridge, Prostate Organoids for Early disease research and Treatments (POET) study
Fatima Dhalla, University of Oxford, Identifying novel candidate genes for inborn errors of thymic stromal cells that cause severe congenital T-cell lymphopaenia
Wen Ding, University of Bristol, Progressing the Clinical Applicability of Adeno-Associated Virus Gene Therapy for Genetic Nephrotic Syndrome
Sherif Elsharkawy, King's College London, Biomineralization Of White Spot Dental Enamel Lesions Via A Protein-based Approach ‘‘KERATINAMEL’’
Nicholas Evans, University of Cambridge School of Clinical Medicine, Dual PET Evaluation of Inflammation across the Neurovascular Interface in Cerebrovascular Disease
Douglas Fink, London School of Hygiene and Tropical Medicine, Regulation of innate immunity by epigenetic control of endogenous retroelements
Jonathan Fisher, University College London, Supporting homing and longevity of gamma delta T cells for cancer immunotherapy
Iram Haq, Newcastle University, Investigating the effects of CFTR modulators on the epithelial sodium channel (ENaC) in the cystic fibrosis airway
Ann Louise Hunter, University of Manchester, Applying genomic technologies to understand adipose inflammation
Keaton Jones, University of Oxford, Macrophage repolarisation in murine pancreatic cancer
Harriet Kemp, Imperial College London, A feasibility study investigating novel longitudinal cutaneous markers of neuropathic pain
Katharine Lodge, Imperial College London, The role of hypoxia in neutrophil-mediated endothelial dysfunction: application to inflammatory lung disease
Alexander Mentzer, University of Oxford, Long range sequencing of the human immunoglobulin loci to direct early diagnostics and functional gene-antibody correlations in COVID-19 disease
Muhummad Sohaib Nazir, King's College London, Imaging guided in-vivo histological validation of cardiac sarcoid using 68Ga- DOTATATE and novel PET-MR methods
Naaventhan Palaniyappan, University of Nottingham, Repurposing Sirolimus in Cirrhosis: Assessing Response with Magnetic Resonance Imaging (MRI)
Valeria Parlatini, King's College London, Understanding the impact of the Covid-19 pandemic on the mental health of children and young people with pre-existing mental health conditions
Amit Sud, Institute of Cancer Research, Defining the genomic landscape of acute myeloid leukaemia in adults using whole genome sequencing
Oliver Van Hecke, University of Oxford, Using a child’s antibiotic history as a data-enabled brief intervention to optimise antibiotic prescribing in children with acute respiratory tract infections in general practice: a feasibility study
Paul Vulliamy, Queen Mary University of London, Platelet-mediated immunomodulation after major trauma
Emily Watts, University of Edinburgh, Dissecting the role of the mTORC/AMPK axis in neutrophil mediated lung injury
Katie Williams, King's College London, Investigation of axial length variation and myopia in health and disease
Daisy Wilson, University of Birmingham Medical School, Covid-19 model of acute sarcopenia recovery: investigating immune-muscle interactions
Bernadette Young, University of Oxford, Investigating the role of bacterial genomic adaptation in orthopaedic infection
Sarah Aitken, University of Cambridge, The molecular pathology of liver cancer: multi-omics dissection of liver cancer in transplant patients
Matthew Booker, University of Bristol, REMote Advice for Prehospital Professionals (REMAPP): a conversation analytic study of clinical telephone advice
Anob Chakrabarti, Francis Crick Institute, Modelling regulatory mechanisms of RNP condensation in neuronal development: insights into neurodegeneration
Elizabeth Curtis, University of Southampton, Does maternal gestational vitamin D supplementation influence offspring DNA methylation in childhood?
Jim Dunham, University of Bristol, Exploration of human C-nociceptor pathophysiology
Kiterie Faller, University of Edinburgh, Fuelling Motor Neuron Diseases – A Systematic Study of Energy Metabolism in ALS and SMA.
Rebecca Geddes, Royal Veterinary College, University of London, Establishing the domestic cat as a novel model of spontaneous nephrolithiasis by investigation of the genetic basis of disease
Michael James Gilhooley, University College London, Single retinal ganglion cell transcriptomics in models of hereditary optic neuropathy
Kathryn Griffin, University of Leeds, Developing light sheet microscopy of murine and human gut to assess (pre)diabetic microvascular disease
Katharina Kohler, University of Cambridge, Data driven modelling of emergency surgical services
Emily Lees, University of Oxford, Investigating the interactions of Salmonellae with the human intestinal epithelium and macrophages
Gulraj Matharu, University of Bristol, What is the clinical effectiveness of regional anaesthesia compared with general anaesthesia for post-operative complications in patients with hip fractures?
Laura McCreight, University of Dundee School of Medicine, Using C-Peptide measurement to clarify, simplify and personalise the management of diabetes (CLASP): CLARIFY.
Robert McCutcheon, King's College London, Excitation/Inhibition Balance in Autism Spectrum Disorder and Schizophrenia: Building A Multi-Scale Understanding
Maria Prendecki, Imperial College London, The role of low density granulocytes in the pathogenesis of anti-neutrophil cytoplasm antibody associated vasculitis
Elizabeth Radford, University of Cambridge, Transforming diagnostic certainty in developmental disorders using CRISPR-based saturation genome editing
Laura Randall, University of Nottingham, Evaluating the novel use of mass-spectrometry based approaches for investigating the pathogenesis of lameness in dairy cattle
Patrick Redmond, King's College London, Development of a complex intervention to optimise safe prescribing for older people in general practice post hospitalisation
Anna Rose, University of Oxford, Development of oncolytic viruses for treatment of ATRX-deficient paediatric brain and bone tumours
Panicos Shangaris, King's College London, In Utero Therapy for the Induction of Immune Tolerance
Sanooj Soni, Imperial College London, Microvesicle-mediated signalling during acute lung injury: Defining the role of acid sphingomyelinase
Andrew Stewart, University of Cambridge School of Clinical Medicine, Investigating the cellular and microvesicle content of human urine in health and disease
Danielle Whittaker, King's College London, Investigating cerebellar GABAergic cell specification in a novel recessive syndrome with cerebellar hypoplasia and hypogonadotropic hypogonadism
Svetislav Zaric, King's College London, Derivation and validation of microbe-associated-molecular-patterns-based biomarkers for personalised periodontal medicine
The scheme is generously supported by the Wellcome Trust, Medical Research Council, British Heart Foundation, Arthritis Research UK, Royal College of Physicians and Diabetes UK.
The scheme is generously supported by the Wellcome Trust, Medical Research Council, British Heart Foundation, Versus Arthritis, Diabetes UK, the British Thoracic Society (through the Helen and Andrew Douglas bequest), and the Association of Physicians of Great Britain & Ireland.
Tel: –View staff bio
Tel: 020 3141 3271View staff bio
Tel: -View staff bio